Informations générales (source: ClinicalTrials.gov)
Electronic-personalized Program for Obesity in Pregnancy to Improve Delivery - ePPOP Study (ePPOP-ID)
Interventional
N/A
University Hospital, Lille (Voir sur ClinicalTrials)
novembre 2017
novembre 2023
04 janvier 2025
The purpose of this study is to assess the efficacy of an electronic-based intervention
to help pregnant overweight and obese women gain an appropriate amount of weight and
improve their delivery i.e. to reduce the rate of labour procedures and interventions. We
chose a composite outcome including instrumental delivery and Caesarean section, as
clinically relevant outcomes because the mode of delivery is one of the major goals of
the obstetrical management and is is strongly associated with body mass index and
gestational weight gain.
Etablissements
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
CHU Lille - Lille - France | Sylvie Deghilage | Contact (sur clinicalTrials) |
Critères
Femme
Inclusion Criteria:
- Obese pregnant women (30 ≤ BMI < 40 kg/m2)
- Singleton pregnancy between 12+0 to 19+6 weeks of pregnancy
- Having an email address and an Internet access
- Obese pregnant women (30 ≤ BMI < 40 kg/m2)
- Singleton pregnancy between 12+0 to 19+6 weeks of pregnancy
- Having an email address and an Internet access
- BMI < 30 kg/m2 or BMI > 40 kg/m2
- History of more than 2 miscarriages
- Severe heart disease (arrhythmias, history of myocardial infarction)
- Multiple pregnancy
- Unstable thyroid disease
- Uncontrolled hypertension
- Pre-gestational diabetes
- Bariatric surgery
- Any medical condition that may interfere with physical activity during pregnancy
- No access to Internet
- Minor
- Absence of health insurance
- Guardianship
- Refusal to participate in research